Advertisement

Topics

TGen-led canine melanoma study identifies genetic basis of disease; potential drug targets

20:00 EDT 6 Sep 2018 | AAAS

(The Translational Genomics Research Institute) TGen and its collaborators from across the nation used multiple genomic analysis techniques to identify several gene mutations that could be the keys to what drives melanoma in dogs. Following the path from human melanoma, the findings of recurring molecular changes in canine melanoma can help veterinary physicians pinpoint potential new treatments for dogs. Likewise, human physicians will view these changes in light of the type of melanoma that occurs in non-sun exposed areas in the mouth, or other mucosal surfaces.

Original Article: TGen-led canine melanoma study identifies genetic basis of disease; potential drug targets

NEXT ARTICLE

More From BioPortfolio on "TGen-led canine melanoma study identifies genetic basis of disease; potential drug targets"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Melanoma
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....